KR101476271B1 - 초고감도 및 높은 선택성을 갖는 구리이온 검출용 조성물 및 형광화학센서 - Google Patents
초고감도 및 높은 선택성을 갖는 구리이온 검출용 조성물 및 형광화학센서 Download PDFInfo
- Publication number
- KR101476271B1 KR101476271B1 KR1020130066459A KR20130066459A KR101476271B1 KR 101476271 B1 KR101476271 B1 KR 101476271B1 KR 1020130066459 A KR1020130066459 A KR 1020130066459A KR 20130066459 A KR20130066459 A KR 20130066459A KR 101476271 B1 KR101476271 B1 KR 101476271B1
- Authority
- KR
- South Korea
- Prior art keywords
- phosphor
- quencher
- copper ion
- copper ions
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 title claims abstract description 163
- 229910001431 copper ion Inorganic materials 0.000 title claims abstract description 162
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000001514 detection method Methods 0.000 claims abstract description 44
- 239000002738 chelating agent Substances 0.000 claims abstract description 27
- 239000000126 substance Substances 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 23
- 210000002966 serum Anatomy 0.000 claims abstract description 19
- 230000000694 effects Effects 0.000 claims abstract description 13
- 238000012216 screening Methods 0.000 claims abstract description 6
- 210000002381 plasma Anatomy 0.000 claims abstract description 4
- 210000002700 urine Anatomy 0.000 claims abstract description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 65
- 125000002355 alkine group Chemical group 0.000 claims description 32
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 claims description 31
- 239000010949 copper Substances 0.000 claims description 29
- 230000000171 quenching effect Effects 0.000 claims description 19
- 238000010791 quenching Methods 0.000 claims description 17
- 239000003638 chemical reducing agent Substances 0.000 claims description 16
- 238000012360 testing method Methods 0.000 claims description 14
- 210000004027 cell Anatomy 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 239000013592 cell lysate Substances 0.000 claims description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 2
- 210000002751 lymph Anatomy 0.000 claims description 2
- 210000003296 saliva Anatomy 0.000 claims description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 230000003834 intracellular effect Effects 0.000 abstract description 5
- 239000012472 biological sample Substances 0.000 abstract description 4
- 238000009007 Diagnostic Kit Methods 0.000 abstract description 2
- 238000013537 high throughput screening Methods 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 16
- 150000001875 compounds Chemical class 0.000 description 13
- 150000002500 ions Chemical class 0.000 description 10
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 229910052802 copper Inorganic materials 0.000 description 9
- 230000003247 decreasing effect Effects 0.000 description 9
- 229910021645 metal ion Inorganic materials 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- -1 alkyne compounds Chemical class 0.000 description 6
- 150000001540 azides Chemical class 0.000 description 6
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- RMNAJNJBCBFOKX-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanamine Chemical compound NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-] RMNAJNJBCBFOKX-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 238000004451 qualitative analysis Methods 0.000 description 4
- 238000004445 quantitative analysis Methods 0.000 description 4
- 238000011894 semi-preparative HPLC Methods 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 3
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 3
- ZSFGTBJYBWJOLZ-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanamine Chemical compound NCCOCCOCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-] ZSFGTBJYBWJOLZ-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 230000008033 biological extinction Effects 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229960001639 penicillamine Drugs 0.000 description 3
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 3
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- VCQSTKKJKNUQBI-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanamine Chemical compound NCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-] VCQSTKKJKNUQBI-UHFFFAOYSA-N 0.000 description 2
- VUGCBIWQHSRQBZ-UHFFFAOYSA-N 2-methylbut-3-yn-2-amine Chemical compound CC(C)(N)C#C VUGCBIWQHSRQBZ-UHFFFAOYSA-N 0.000 description 2
- SDYAJRBHPPWHSF-UHFFFAOYSA-N 4-azidoaniline;hydrochloride Chemical compound Cl.NC1=CC=C(N=[N+]=[N-])C=C1 SDYAJRBHPPWHSF-UHFFFAOYSA-N 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- BTDWSZJDLLLTMI-UHFFFAOYSA-N hex-2-yn-1-ol Chemical compound CCCC#CCO BTDWSZJDLLLTMI-UHFFFAOYSA-N 0.000 description 2
- KARLLBDFLHNKBO-UHFFFAOYSA-N hex-4-yn-3-ol Chemical compound CCC(O)C#CC KARLLBDFLHNKBO-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- JKANAVGODYYCQF-UHFFFAOYSA-N prop-2-yn-1-amine Chemical compound NCC#C JKANAVGODYYCQF-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 235000010378 sodium ascorbate Nutrition 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- DOMDXTIMIZCSNC-UHFFFAOYSA-N (2Z)-2-[(2E,4E)-5-[3-[6-(2,5-dioxopyrrolidin-1-yl)oxy-6-oxohexyl]-1,1-dimethyl-6,8-disulfobenzo[e]indol-3-ium-2-yl]penta-2,4-dienylidene]-3-ethyl-1,1-dimethyl-8-sulfobenzo[e]indole-6-sulfonate Chemical compound CC1(C)C(C2=CC(=CC(=C2C=C2)S([O-])(=O)=O)S(O)(=O)=O)=C2N(CC)\C1=C/C=C/C=C/C(C(C1=C2C=C(C=C(C2=CC=C11)S(O)(=O)=O)S(O)(=O)=O)(C)C)=[N+]1CCCCCC(=O)ON1C(=O)CCC1=O DOMDXTIMIZCSNC-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- NNKQLUVBPJEUOR-UHFFFAOYSA-N 3-ethynylaniline Chemical compound NC1=CC=CC(C#C)=C1 NNKQLUVBPJEUOR-UHFFFAOYSA-N 0.000 description 1
- HZVTZSFWPLLBRF-UHFFFAOYSA-N 4-chlorobut-2-ynylazanium;chloride Chemical compound Cl.NCC#CCCl HZVTZSFWPLLBRF-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000018839 Wilson disease Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 150000001345 alkine derivatives Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- OTJZCIYGRUNXTP-UHFFFAOYSA-N but-3-yn-1-ol Chemical compound OCCC#C OTJZCIYGRUNXTP-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010013932 dyslexia Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- IFCAMPHNVKBSTF-UHFFFAOYSA-N hex-3-yn-2-ol Chemical compound CCC#CC(C)O IFCAMPHNVKBSTF-UHFFFAOYSA-N 0.000 description 1
- KSOMTIQGBYHOJM-UHFFFAOYSA-N hex-5-en-2-yn-1-ol Chemical compound OCC#CCC=C KSOMTIQGBYHOJM-UHFFFAOYSA-N 0.000 description 1
- AJYGRAORQSCNED-UHFFFAOYSA-N hex-5-yn-3-ol Chemical compound CCC(O)CC#C AJYGRAORQSCNED-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000002073 nanorod Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- LMDDPGHBJXJGAC-UHFFFAOYSA-N pent-4-yn-1-amine Chemical compound NCCCC#C LMDDPGHBJXJGAC-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- YUQZOUNRPZBQJK-UHFFFAOYSA-N undec-10-yn-1-ol Chemical compound OCCCCCCCCCC#C YUQZOUNRPZBQJK-UHFFFAOYSA-N 0.000 description 1
- YSDWKSIWEWYTEF-UHFFFAOYSA-N undec-9-yn-1-ol Chemical compound CC#CCCCCCCCCO YSDWKSIWEWYTEF-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000004832 voltammetry Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
- C09K11/07—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials having chemically interreactive components, e.g. reactive chemiluminescent compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1014—Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1022—Heterocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6434—Optrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N2021/7769—Measurement method of reaction-produced change in sensor
- G01N2021/7786—Fluorescence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
도 2는 본 발명의 센서가 다양한 금속이온 중 구리이온에만 선택적으로 반응함을 보여준다.
도 3은 본 발명의 센서의 구리이온 검출에 소요되는 시간을 보여준다.
도 4는 본 발명의 센서가 금속 혼합물에서 구리이온에만 선택적으로 반응함을 보여준다. 빨강 막대: Li+, Ca2+, Ni+ 및 Hg2+의 혼합물; 녹색 막대: Mg2+, K+, Pd2+ 및 Co2+의 혼합물; 파랑 막대: Mn2+, Cd2+, Fe2+ 및 Ag+의 혼합물.
도 5는 본 발명의 센서의 검출한계를 보여준다.
도 6은 본 발명의 센서로 구리 킬레이트제의 효능을 평가할 수 있음을 보여준다.
도 7은 본 발명의 센서로 세포 내 구리이온을 검출할 수 있음을 보여준다.
도 8은 본 발명의 센서로 혈청 내 구리이온의 양을 정량할 수 있음을 보여준다.
Claims (11)
- 형광체; 및 상기 형광체의 발광효과를 흡수하여 소광효과를 나타내는 소광체를 포함하고, 상기 형광체 및 소광체는 각각 아자이드(azide) 그룹 또는 알킨(alkyne) 그룹을 포함하되, 형광체가 아자이드 그룹을 포함하는 경우 소광체는 알킨 그룹을 포함하고, 형광체가 알킨 그룹을 포함하는 경우 소광체는 아자이드 그룹을 포함하는 것을 특징으로 하는 구리이온 검출용 조성물.
- 제 1 항에 있어서, 상기 형광체는 적색 또는 근적외선의 형광을 발광하는 것을 특징으로 하는 조성물.
- 제 1 항에 있어서, 상기 형광체는 시아닌(Cyanine), 플루오레신(fluorescein), 보디피(BODIPY), 테트라메틸로드아민(Trtramethylrhodamine), 알렉사(Alexa) 및 알로피코시아닌(allopicocyanine)으로 구성된 군으로부터 선택되는 것을 특징으로 하는 조성물.
- 제 1 항에 있어서, 상기 소광체는 블랙홀 소광체(blackhole quencher, BHQ) 또는 블랙베리 소광체(blackberry quencher, BBQ)인 것을 특징으로 하는 조성물.
- 제 1 항 내지 제 4 항 중 어느 한 항에 따른 구리이온 검출용 조성물을 포함하는 구리이온 검출용 형광화학센서.
- 다음의 단계를 포함하는 구리이온 검출용 조성물의 제조방법:
(a) 아자이드 그룹 또는 알킨 그룹이 도입된 형광체를 얻는 단계;
(b) 알킨 그룹 또는 아자이드 그룹이 도입된 소광체를 얻는 단계; 및
(c) 단계 (a)에서 얻은 아자이드 그룹이 도입된 형광체와 단계 (b)에서 얻은 알킨 그룹이 도입된 소광체, 또는 단계 (a)에서 얻은 알킨 그룹이 도입된 형광체와 단계 (b)에서 얻은 아자이드 그룹이 도입된 소광체를 혼합하는 단계.
- 다음의 단계를 포함하는 시료 내 구리이온의 선택적 검출방법:
(a) 제 1 항의 구리이온 검출용 조성물 또는 제 5 항의 구리이온 검출용 형광화학센서에 시료를 접촉시키는 단계; 및
(b) 형광체의 소광을 확인하는 단계.
- 제 7 항에 있어서, 상기 형광체의 소광은 시료 내에 구리이온이 존재하는 경우에 발생하는 것을 특징으로 하는 검출방법.
- 제 7 항에 있어서, 상기 시료는 수용액, 유기용액, 세포, 세포 용해물(cell lysate), 혈액, 혈장, 혈청, 림프, 타액, 뇨, 정액 및 복수로 구성된 군으로부터 선택되는 것을 특징으로 하는 검출방법.
- 다음의 단계를 포함하는 구리이온 킬레이트제의 스크리닝 방법:
(a) 환원제를 포함하는 제 1 항의 구리이온 검출용 조성물 또는 환원제를 포함하는 제 5 항의 구리이온 검출용 형광화학센서에 시험물질과 구리이온(Cu2+)을 동시에 또는 순차적으로 접촉시키는 단계; 및
(b) 상기 형광체의 소광을 확인하는 단계.
- 다음의 단계를 포함하는 구리이온 킬레이트제의 킬레이트 효과 확인 방법:
(a) 환원제를 포함하는 제 1 항의 구리이온 검출용 조성물 또는 환원제를 포함하는 제 5 항의 구리이온 검출용 형광화학센서에 구리이온 킬레이트제와 구리이온(Cu2+)을 동시에 또는 순차적으로 접촉시키는 단계; 및
(b) 상기 형광체의 소광을 확인하는 단계.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130066459A KR101476271B1 (ko) | 2013-06-11 | 2013-06-11 | 초고감도 및 높은 선택성을 갖는 구리이온 검출용 조성물 및 형광화학센서 |
PCT/KR2013/010418 WO2014200164A1 (ko) | 2013-06-11 | 2013-11-15 | 초고감도 및 높은 선택성을 갖는 구리이온 검출용 조성물 및 형광화학센서 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130066459A KR101476271B1 (ko) | 2013-06-11 | 2013-06-11 | 초고감도 및 높은 선택성을 갖는 구리이온 검출용 조성물 및 형광화학센서 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140144474A KR20140144474A (ko) | 2014-12-19 |
KR101476271B1 true KR101476271B1 (ko) | 2014-12-24 |
Family
ID=52022434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130066459A Expired - Fee Related KR101476271B1 (ko) | 2013-06-11 | 2013-06-11 | 초고감도 및 높은 선택성을 갖는 구리이온 검출용 조성물 및 형광화학센서 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101476271B1 (ko) |
WO (1) | WO2014200164A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101812200B1 (ko) * | 2017-09-27 | 2018-01-30 | 주식회사 써지랩 | 개인용 피부 관리 마스크 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104893712B (zh) * | 2015-05-22 | 2016-11-09 | 济南大学 | 一种新型高选择性二价铜离子荧光探针及其制备方法与生物应用 |
CN104849271B (zh) * | 2015-05-26 | 2017-06-30 | 中国科学院烟台海岸带研究所 | 一种基于花菁的探针用于检测痕量二价铜离子的方法 |
KR102368068B1 (ko) * | 2015-08-24 | 2022-02-25 | 삼성전자주식회사 | 반도체 소자 제조용 조성물 및 이를 이용하는 반도체 소자의 제조 방법 |
CN106018365B (zh) * | 2016-05-19 | 2019-08-06 | 南京林业大学 | 山奈酚与环糊精的复配液及其应用 |
CN110713826B (zh) * | 2018-07-14 | 2022-11-18 | 湖南科技大学 | 基于邻炔基苯并唑的铜离子检测探针及其制备方法和应用 |
CN110907421B (zh) * | 2019-12-13 | 2022-06-17 | 深圳市人民医院 | 一种基于石墨炔和点击化学的铜离子的检测方法、试剂盒以及应用 |
CN111122482A (zh) * | 2019-12-27 | 2020-05-08 | 浙江理工大学 | 一种取代聚炔型水相二价铜离子检测探针的制备方法及其产品和应用 |
CN112748261A (zh) * | 2020-12-21 | 2021-05-04 | 中国计量大学上虞高等研究院有限公司 | 一种检测水溶液中铜离子的方法 |
CN113390840A (zh) * | 2021-06-12 | 2021-09-14 | 宁德师范学院 | 一种碳点的合成及水体中铜离子检测方法 |
CN117554401B (zh) * | 2024-01-12 | 2024-04-02 | 沧州市天津工业大学研究院 | 基于膜富集与x-射线荧光联用检测水中重金属的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090097704A (ko) * | 2008-03-12 | 2009-09-16 | 인하대학교 산학협력단 | 구리 또는 아연 이온의 선택적 검출용 형광 펩타이드 센서및 그 제조 방법 |
KR101210934B1 (ko) * | 2011-09-26 | 2012-12-11 | 연세대학교 산학협력단 | 구리 및 시아나이드 이온의 선택적 검출이 가능한 형광센서, 그 제조방법 및 이를 이용한 구리 및 시아나이드 이온의 선택적 검출방법 |
-
2013
- 2013-06-11 KR KR1020130066459A patent/KR101476271B1/ko not_active Expired - Fee Related
- 2013-11-15 WO PCT/KR2013/010418 patent/WO2014200164A1/ko active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090097704A (ko) * | 2008-03-12 | 2009-09-16 | 인하대학교 산학협력단 | 구리 또는 아연 이온의 선택적 검출용 형광 펩타이드 센서및 그 제조 방법 |
KR101210934B1 (ko) * | 2011-09-26 | 2012-12-11 | 연세대학교 산학협력단 | 구리 및 시아나이드 이온의 선택적 검출이 가능한 형광센서, 그 제조방법 및 이를 이용한 구리 및 시아나이드 이온의 선택적 검출방법 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101812200B1 (ko) * | 2017-09-27 | 2018-01-30 | 주식회사 써지랩 | 개인용 피부 관리 마스크 |
Also Published As
Publication number | Publication date |
---|---|
KR20140144474A (ko) | 2014-12-19 |
WO2014200164A1 (ko) | 2014-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101476271B1 (ko) | 초고감도 및 높은 선택성을 갖는 구리이온 검출용 조성물 및 형광화학센서 | |
Li et al. | Chromogenic and fluorogenic chemosensors for hydrogen sulfide: review of detection mechanisms since the year 2009 | |
Dai et al. | Tailoring tripodal ligands for zinc sensing | |
Salinas-Castillo et al. | Carbon dots for copper detection with down and upconversion fluorescent properties as excitation sources | |
Song et al. | A lanthanide‐complex‐based ratiometric luminescent probe specific for peroxynitrite | |
Gao et al. | Sensitive water-soluble fluorescent probe based on umpolung and aggregation-induced emission strategies for selective detection of Hg2+ in living cells and zebrafish | |
Tang et al. | A Sensitive and Selective Near‐Infrared Fluorescent Probe for Mercuric Ions and Its Biological Imaging Applications | |
Rajamanikandan et al. | Protein-protected red emittive copper nanoclusters as a fluorometric probe for highly sensitive biosensing of creatinine | |
Chen et al. | A low background D–A–D type fluorescent probe for imaging of biothiols in living cells | |
Wu et al. | Fluorogenic toolbox for facile detecting of hydroxyl radicals: From designing principles to diagnostics applications | |
Christ et al. | Chemical sensing and imaging based on photon upconverting nano-and microcrystals: a review | |
Huang et al. | Ag@ Au nanoprism-metal organic framework-based paper for extending the glucose sensing range in human serum and urine | |
Zhang et al. | A chemiluminescent probe for highly sensitive detection of carbon monoxide in aqueous solution and air | |
WO2015097262A1 (en) | Fluorescent red emitting functionalizable ph probes | |
Zhang et al. | A phenazine-barbituric acid based colorimetric and ratiometric near-infrared fluorescent probe for sensitively differentiating biothiols and its application in TiO 2 sensor devices | |
Shanmugaraj et al. | A “turn-off” fluorescent sensor for the selective and sensitive detection of copper (ii) ions using lysozyme stabilized gold nanoclusters | |
Long et al. | Fluorinated near-infrared fluorescent probes for specific detection of Hg 2+ in an aqueous medium and mitochondria of living cells | |
CN106518800B (zh) | 一种基于氢离子激活的双响应检测ClO-/H2S荧光分子探针的制备方法及应用 | |
Wang et al. | A fluorescence and resonance Rayleigh scattering di-model probe was developed for trace K+ coupled N-doped carbon dot and aptamer | |
Seo et al. | Single-photon-driven up-/down-conversion nanohybrids for in vivo mercury detection and real-time tracking | |
Kong et al. | A golgi apparatus‐targetable probe based on lanthanide complexes for ratiometric time‐gated luminescence detection of hydrogen sulfide | |
Kumar et al. | Fast tyrosinase detection in early stage melanoma with nanomolar sensitivity using a naphthalimide-based fluorescent read-out probe | |
Jothi et al. | Benzothiazole appended 2, 2′-(1, 4-phenylene) diacetonitrile for the colorimetric and fluorescence detection of cyanide ions | |
Connally et al. | Time‐resolved fluorescence microscopy using an improved europium chelate BHHST for the in situ detection of Cryptosporidium and Giardia | |
Wang et al. | Ultrabright chemiluminescent scaffold for portable visualizing organophosphorus compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20130611 |
|
PA0201 | Request for examination | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20140624 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20141216 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20141218 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20141219 End annual number: 3 Start annual number: 1 |
|
PG1501 | Laying open of application | ||
PG1601 | Publication of registration | ||
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20180929 |